Table of Contents

2019-2024 Global Anti-infective Ophthalmic Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Anti-infective Ophthalmic Consumption 2014-2024
  • 2.1.2 Anti-infective Ophthalmic Consumption CAGR by Region
• 2.2 Anti-infective Ophthalmic Segment by Type
  • 2.2.1 Antibacterial
  • 2.2.2 Antiviral
  • 2.2.3 Antifungal
  • 2.2.4 Anti-parasitic
  • 2.2.5 Others
• 2.3 Anti-infective Ophthalmic Consumption by Type
  • 2.3.1 Global Anti-infective Ophthalmic Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Anti-infective Ophthalmic Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Anti-infective Ophthalmic Sale Price by Type (2014-2019)
• 2.4 Anti-infective Ophthalmic Segment by Application
  • 2.4.1 Hospital Use
  • 2.4.2 Clinic Use
  • 2.4.3 Household
  • 2.4.4 Other
• 2.5 Anti-infective Ophthalmic Consumption by Application
  • 2.5.1 Global Anti-infective Ophthalmic Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Anti-infective Ophthalmic Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Anti-infective Ophthalmic Sale Price by Application (2014-2019)

3 Global Anti-infective Ophthalmic by Players

• 3.1 Global Anti-infective Ophthalmic Sales Market Share by Players
  • 3.1.1 Global Anti-infective Ophthalmic Sales by Players (2017-2019)
  • 3.1.2 Global Anti-infective Ophthalmic Sales Market Share by Players (2017-2019)
• 3.2 Global Anti-infective Ophthalmic Revenue Market Share by Players
  • 3.2.1 Global Anti-infective Ophthalmic Revenue by Players (2017-2019)
  • 3.2.2 Global Anti-infective Ophthalmic Revenue Market Share by Players (2017-2019)
• 3.3 Global Anti-infective Ophthalmic Sale Price by Players
• 3.4 Global Anti-infective Ophthalmic Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Anti-infective Ophthalmic Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Anti-infective Ophthalmic Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Anti-infective Ophthalmic by Regions

• 4.1 Anti-infective Ophthalmic by Regions
  • 4.1.1 Global Anti-infective Ophthalmic Consumption by Regions
  • 4.1.2 Global Anti-infective Ophthalmic Value by Regions
• 4.2 Americas Anti-infective Ophthalmic Consumption Growth
• 4.3 APAC Anti-infective Ophthalmic Consumption Growth
• 4.4 Europe Anti-infective Ophthalmic Consumption Growth
• 4.5 Middle East & Africa Anti-infective Ophthalmic Consumption Growth

5 Americas

• 5.1 Americas Anti-infective Ophthalmic Consumption by Countries
  • 5.1.1 Americas Anti-infective Ophthalmic Consumption by Countries (2014-2019)
  • 5.1.2 Americas Anti-infective Ophthalmic Value by Countries (2014-2019)
• 5.2 Americas Anti-infective Ophthalmic Consumption by Type
• 5.3 Americas Anti-infective Ophthalmic Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Anti-infective Ophthalmic Consumption by Countries
  • 6.1.1 APAC Anti-infective Ophthalmic Consumption by Countries (2014-2019)
  • 6.1.2 APAC Anti-infective Ophthalmic Value by Countries (2014-2019)
• 6.2 APAC Anti-infective Ophthalmic Consumption by Type
• 6.3 APAC Anti-infective Ophthalmic Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Anti-infective Ophthalmic by Countries
  • 7.1.1 Europe Anti-infective Ophthalmic Consumption by Countries (2014-2019)
  • 7.1.2 Europe Anti-infective Ophthalmic Value by Countries (2014-2019)
• 7.2 Europe Anti-infective Ophthalmic Consumption by Type
• 7.3 Europe Anti-infective Ophthalmic Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Anti-infective Ophthalmic by Countries
  • 8.1.1 Middle East & Africa Anti-infective Ophthalmic Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Anti-infective Ophthalmic Value by Countries (2014-2019)
• 8.2 Middle East & Africa Anti-infective Ophthalmic Consumption by Type
• 8.3 Middle East & Africa Anti-infective Ophthalmic Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Anti-infective Ophthalmic Distributors
• 10.3 Anti-infective Ophthalmic Customer

11 Global Anti-infective Ophthalmic Market Forecast

• 11.1 Global Anti-infective Ophthalmic Consumption Forecast (2019-2024)
• 11.2 Global Anti-infective Ophthalmic Forecast by Regions
  • 11.2.1 Global Anti-infective Ophthalmic Forecast by Regions (2019-2024)
  • 11.2.2 Global Anti-infective Ophthalmic Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Anti-infective Ophthalmic Forecast by Type
• 11.8 Global Anti-infective Ophthalmic Forecast by Application

12 Key Players Analysis

• 12.1 Novartis
  • 12.1.1 Company Details
  • 12.1.2 Anti-infective Ophthalmic Product Offered
  • 12.1.3 Novartis Anti-infective Ophthalmic Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Novartis News
• 12.2 Allergan
  • 12.2.1 Company Details
  • 12.2.2 Anti-infective Ophthalmic Product Offered
  • 12.2.3 Allergan Anti-infective Ophthalmic Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Allergan News
• 12.3 Valeant Pharmaceuticals
  • 12.3.1 Company Details
  • 12.3.2 Anti-infective Ophthalmic Product Offered
  • 12.3.3 Valeant Pharmaceuticals Anti-infective Ophthalmic Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Valeant Pharmaceuticals News
• 12.4 Santen Pharmaceutical
  • 12.4.1 Company Details
  • 12.4.2 Anti-infective Ophthalmic Product Offered
  • 12.4.3 Santen Pharmaceutical Anti-infective Ophthalmic Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Santen Pharmaceutical News
• 12.5 Lupin Pharmaceuticals
  • 12.5.1 Company Details
  • 12.5.2 Anti-infective Ophthalmic Product Offered
  • 12.5.3 Lupin Pharmaceuticals Anti-infective Ophthalmic Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Lupin Pharmaceuticals News
• 12.6 Apotex
  • 12.6.1 Company Details
  • 12.6.2 Anti-infective Ophthalmic Product Offered
  • 12.6.3 Apotex Anti-infective Ophthalmic Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Apotex News
• 12.7 Akorn
  • 12.7.1 Company Details
  • 12.7.2 Anti-infective Ophthalmic Product Offered
  • 12.7.3 Akorn Anti-infective Ophthalmic Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Akorn News

...

13 Research Findings and Conclusion

Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
In terms of region, the global ophthalmic anti-infective market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global ophthalmic anti-infective market due to availability of advanced drug formulations in the region. Awareness among people about diseases is also a major factor boosting the market in the region. The ophthalmic anti-infective market in Asia Pacific is anticipated to expand at a rapid pace due to increase in incidence of eye infection in the region. Lack of awareness about diseases and unavailability of advanced medication and formulations in underdeveloped countries, such as Lebanon, Syria, Cyprus, Turkey, and Iraq are likely to restrain the growth of the ophthalmic anti-infective market in Middle East & Africa.

According to this study, over the next five years the Anti-infective Ophthalmic market will register a xx% CAGR in terms of revenue, the global market size will reach US$ 1410 million by 2024, from US$ 1410 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anti-infective Ophthalmic business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-infective Ophthalmic market by product type, application, key manufacturers and key regions and countries.

This study considers the Anti-infective Ophthalmic value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Antibacterial
Antiviral
Antifungal
Anti-parasitic
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital Use
Clinic Use
Household
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
Allergan
Valeant Pharmaceuticals
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Anti-infective Ophthalmic consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Anti-infective Ophthalmic market by identifying its various subsegments.
Focuses on the key global Anti-infective Ophthalmic manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anti-infective Ophthalmic with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Anti-infective Ophthalmic submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.